All Type of News
Combined sales of top 5 drug makers top 2.54 trillion won in 2007
The country's top five pharmaceutical firms Dong-A, Hanmi, Yuhan, Daewoong and Green Cross posted 2.54 trillion won in their combined sales last year, according to Yakup Shinmoon.
Dong-A led any others with i...
Insurance price of Sprycel to be determined at end of March
The Ministry of Health, Welfare and Family Affairs said the insurance price of Sprycel would be finally determined at the end of this month as the National Health Insurance Corporation and BMS Korea failed to reach an...
Boryung seeks additional indication of Astrix
Boryung Pharm has tried to expand the treatment scope of Astrix (aspirin 100 mg) to cardiovascular disease (i.e., hypertension), citing that the benefit of aspirin for patients with known CVD is well established.
N...
Daewoong to maximize Olmetec sales
Daewoong Pharm and Daiichi Sankyo Korea plan to co-promote Olmetec (olmesartan medoxomi), a selective AT1 subtype angiotensin II receptor antagonist, from April 1. Olmetec, a prodrug, is hydrolyzed to olmesartan durin...
GSK receives KFDA approval for Rotarix vaccine for Rotavirus
GlaxoSmithKline says it has received the Korea Food and Drug Administration approval to market Rotarix vaccine given to children for the prevention of gastroenteritis caused by rotavirus.
The rotavirus vaccine is a...
Kim Soung-yee takes offices
Minister of Health, Welfare and Family Affairs Kim Soung-yee took office on March 13, despite objections from opposition parties for his alleged illicit real estate trading and misappropriation of public funds.
Pre...
Medicines with change in dosage form to be included in incentive list
Newly salt-modified drugs and medicines with change in dosage form will get more incentive in the process of assessing "high quality, cost-effective" drugs, according to the Ministry of Health, Welfare and Family Affa...
Drug makers to map out guideline over third-party support
The Korea Pharmaceutical Manufacturers Association said it will launch its task force team to draw up guidelines aimed at specifying in detail the scope of financial support over the pure scientific events.
The tas...
Pharmaceutical business group urges overhaul of drug pricing policy
The Korea Pharmaceutical Manufacturers Association has urged a new minister of Health, Welfare and Family Affairs to ameliorate the current drug pricing policy, the so-called positive list system, under which only med...
OTC makers see slower sales growth
A red light is on for the nation's OTC makers as their flagship products are not sold as expected earlier, although medicinal plasters have been excluded from the insurance list since last month.
"We cannot paint a...
